Significance of repeated resection for recurrent intrahepatic cholangiocarcinoma

Hepato-Gastroenterology

Volumn 56, Issue 89, 2009, Pages 1-5

  Ohtsuka, M ^a   Kimura, F ^a   Shimizu, H ^a   Yoshidome, H ^a   Kato, A ^a   Yoshitomi, H ^a   Furukawa, K ^a   Mitsuhashi, N ^a   Takeuchi, D ^a   Takayashiki, T ^a   Suda, K ^a   Miyazaki, Masaru ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Intrahepatic cholangiocarcinoma; Recurrence; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER RECURRENCE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHI-SQUARE DISTRIBUTION; CHOLANGIOCARCINOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 64949195473     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211:277-287.
2. Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K, et al: Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 2000; 127:498-505.
3. Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH: Intrahepatic cholangiocarcinoma: respectability, recurrence pattern, and outcomes. J Am Coll Surg 2001; 193:384-391.
4. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Shimizu Y, et al: Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002; 89:1525-1531.
5. Huang JL, Biehl TR, Lee FT, Zimmer PW, Ryan Jr JA: Outcomes after resection of cholangiocellular carcinoma. Am J Surg 2004;187:612-617.
6. Yamamoto M, Takasaki K, Otsubo T, Katsuragawa H, Katagiri S: Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2001; 8:154-157.
7. Cherqui D, Tantawi B, Alon R, Piedbois P, Rahmouni A, Dhumeaux D, et al: Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. Arch Surg 1995;130:1073-1078.
8. Suzuki S, Sakaguchi T, Yokoi Y, Okamoto K, Kurachi K, Tsuchiya Y, et al: Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg 2002; 26:687-693.
9. Sotiropoulos GC, Lang H, Broelsch CE: Surgical management of recurrent intrahepatic cholangiocellular carcinoma after liver resection. Surgery 2005;137:669-670.
10. Kurosaki I, Hatakeyama K: Repeated hepatectomy for recurrent intrahepatic cholangiocarcinoma: report of two cases. Eur J Gastroenterol Hepatol 2005;17:125-130.
11. Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, et al: Fifteen-year, single center experience with the surgical management of intrahepatic choilangiocarcinoma: Operative results and long-term outcome. Surgery 2008;143:366-374.
12. Tonouchi A, Ohtsuka M, Ito H, Kimura F, Shimizu H, Kato M, et al: Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection. Am J Gastroenterol 2006;101:1601-1610.